View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A Phase I/II Study of Pembrolizumab (MK-3475) in Children with advanced melanoma or a PD-L1 positive advanced, relapsed or refractory solid tumor or lymphoma.
  • Protocol ID
    MSD MK-3475-051
  • Disease
    Disease Type Disease Subtype
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Children's Hospital at Westmead
    • Centre Study Status:
      Open
    • Notes:
    Queensland Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
      CPI: Dr Wayne Nicholls. Australia participating in Phase II only.
    Royal Children's Hospital Melbourne
    • Centre Study Status:
      Open
    • Notes:
    Starship Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 1/2
  • Study type
    Treatment
  • Diagnosis stage
    Relapse/refractory
  • Study open date
    04/04/2016
  • Study close date
    N/A
  • Study chair
  • Sponsor
    Merck
Back to search results